Free Account Opening + AMC Free Demat
Loading...

ANG Lifesciences India Ltd IPO Message Board (Page 3)

Loading...
27. Kbgohil |   Link |  Bookmark | September 5, 2017 12:57:07 PM
Allotment hua?
26. lakshya agg |   Link |  Bookmark | September 1, 2017 3:30:24 PM
/ipo/vadivarhe-speciality-ipo/665/


vadivarhe speciality

same story
26.1. Kbgohil |   Link |  Bookmark | September 4, 2017 4:39:35 PM
Allotment and listing kab hai?
25. Kbgohil |   Link |  Bookmark | September 1, 2017 11:57:05 AM
Listed kitane pe hoga?
25.1. lakshya agg |   Link |  Bookmark | September 4, 2017 11:29:00 AM
20% UPPER
24. lakshya agg |   Link |  Bookmark | September 1, 2017 3:25:34 PM
7.8 x
23. Paras securities and consultant pvt Ltd |   Link |  Bookmark | August 31, 2017 10:01:43 PM
Good response from all types category investors.
22. lakshya agg |   Link |  Bookmark | August 31, 2017 4:31:40 PM
5.5x
21. DownriteVJ |   Link |  Bookmark | August 31, 2017 3:22:10 PM
IPO Guru IPO Guru (1400+ Posts, 1200+ Likes)
3.5X
20. Paras securities and consultant pvt Ltd |   Link |  Bookmark | August 31, 2017 2:30:58 PM
strong financial performance of this company.
Apply Apply Apply this SME ipo
20.1. coolaks |   Link |  Bookmark | August 31, 2017 2:56:03 PM
No GMP. I Think this issue will open at discount. If u look at the trackrecord of Guiness Not much listing on same day.it has gone at discount and some issues are have gone up after discount.
No need to apply no QIB/Corporate and HNIs have aplly very less. Retail is more. This will sure shot go down. Open up in discount.
19. abhilovee |   Link |  Bookmark | August 31, 2017 2:05:50 PM
What''s expected listing price of ANG? any idea..
18. lakshya agg |   Link |  Bookmark | August 31, 2017 1:38:16 PM
fair value OF ANG IS RS 135
17. Jay Mangal |   Link |  Bookmark | August 30, 2017 9:31:55 PM
Galaji Ang open me apply kare?
16. neelam |   Link |  Bookmark | August 29, 2017 11:09:54 PM
i review his website and director his self is not having any back of medical knowledge and he is director of pharmasutical company, hup not so good , company director should have study back similar, i am not going ....sorry
16.1. we earn |   Link |  Bookmark | August 30, 2017 7:56:18 PM
Hyyy miss you given a your view on the director.i also checked him profile he studied civil engineering.if you don''t mind you able to check the director of sunpharma what his study then you have a wideview about the director need study about the segment.
Let me explain dilip sangvi is director & founder of sunpharma.he study is b.com....and now sunpharma is no-1 pharma company in India.
My moral is not to prove your analysis wrongs but there is the need of skill of directors this is more important than his education to company.
15. NN |   Link |  Bookmark | August 30, 2017 11:40:31 AM
whether to apply or not plz tell me any one
14. Kbgohil |   Link |  Bookmark | August 29, 2017 11:59:32 PM
NTPC ME KAL KAISE APPLY KAR SHAKTE HAI? KITNE SHARE APPLY KAR SHAKATE HAI?
13. Vimalkaria |   Link |  Bookmark | August 29, 2017 11:40:19 PM
Galaji
Pl advice apply or not
If we hold this sme 3-4 month ?
12. sundark |   Link |  Bookmark | August 26, 2017 11:25:42 AM
How come a SME Company, which doen''t posses an Internet site can come for an IPO?

Don''t they have money to build a website??
Or
Do they operate from backside of the Garage ??

Guys be watchfull.
12.3. Seeking Guidance |   Link |  Bookmark | August 26, 2017 12:01:13 PM
Dont Misguide
Google give first link on searching ANG lifesciences
12.4. neelam |   Link |  Bookmark | August 29, 2017 11:00:34 PM
sir i think you did not got the website online but i got it : http://anglifesciences.com/

please check good website
11. kapil K |   Link |  Bookmark | August 29, 2017 1:47:53 PM
ANG lifescience ipo is good or not ?
10. Saurabh Kumar Agarwal |   Link |  Bookmark | August 28, 2017 9:40:36 PM
Guys please tell how individuals to apply for SME IPO''s
9. NN |   Link |  Bookmark | August 28, 2017 9:00:58 PM
guys plz provide GMP or SUBJECT TO of this IPO
8. Akash Mehta |   Link |  Bookmark | August 27, 2017 4:14:26 PM
Good top line and bottom line growth. Capacity underutilised yet. Looking for tie-ups and expansion. Great return ratios. The issues seems to be reasonably priced when compared to peers.
Having said that the company is actually facing a major working capital crunch. Major risk would be if due to any reason if the company under performs even in a couple of quarters going forward, it will be in trouble.
Still unsure if worth taking the risk.